OA
Oak Associates Portfolio holdings
AUM
$1.53B
This Quarter Return
+11.1%
1 Year Return
+20.93%
3 Year Return
+113.44%
5 Year Return
+164.39%
10 Year Return
+515.4%
AUM
$1.88B
AUM Growth
+$1.88B
(+6.9%)
Cap. Flow
-$33.6M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
46.91%
Holding
142
New
10
Increased
24
Reduced
52
Closed
4
Top Buys
| 1 |
Salesforce
CRM
|
$2.98M |
| 2 |
Calix
CALX
|
$2.25M |
| 3 |
NXP Semiconductors
NXPI
|
$1.94M |
| 4 |
Applied Industrial Technologies
AIT
|
$1.94M |
| 5 |
Medpace
MEDP
|
$1.76M |
Top Sells
| 1 |
KLA
KLAC
|
$15.1M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
$8.13M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$6.17M |
| 4 |
Charles Schwab
SCHW
|
$4.61M |
| 5 |
Microsoft
MSFT
|
$3.41M |
Sector Composition
| 1 | Technology | 42.27% |
| 2 | Communication Services | 15.89% |
| 3 | Consumer Discretionary | 14.27% |
| 4 | Healthcare | 13.2% |
| 5 | Financials | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Verint Systems
VRNT
$1.23B
| $2.32M | 0.12% |
44,220
+15,142
| +52% | +$795K |
|
77
Cencora
COR
$57.2B
| $2.32M | 0.12% |
17,440
| – | – |
|
78
Jazz Pharmaceuticals
JAZZ
$7.99B
| $2.3M | 0.12% |
18,050
| – | – |
|
79
Palo Alto Networks
PANW
$128B
| $2.3M | 0.12% |
4,130
-975
| -19% | -$543K |
|
80
Regeneron Pharmaceuticals
REGN
$59.8B
| $2.26M | 0.12% |
3,575
| – | – |
|
|
81
Calix
CALX
$3.83B
| $2.25M | 0.12% |
+28,149
| New | +$2.25M |
|
|
NXGN
82
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.24M | 0.12% |
125,660
+925
| +0.7% | +$16.5K |
|
83
Concentrix
CNXC
$3.28B
| $2.14M | 0.11% |
12,000
+6,000
| +100% | +$1.07M |
|
84
Cardinal Health
CAH
$36B
| $2.09M | 0.11% |
40,540
+11,000
| +37% | +$566K |
|
85
Tesla
TSLA
$1.08T
| $2.05M | 0.11% |
1,939
-486
| -20% | -$514K |
|
86
Lam Research
LRCX
$124B
| $2M | 0.11% |
2,785
| – | – |
|
|
87
Applied Industrial Technologies
AIT
$9.87B
| $1.94M | 0.1% |
+18,875
| New | +$1.94M |
|
88
Ubiquiti
UI
$33B
| $1.91M | 0.1% |
6,212
| – | – |
|
89
Merck
MRK
$210B
| $1.82M | 0.1% |
23,765
| – | – |
|
90
Exelixis
EXEL
$9.95B
| $1.82M | 0.1% |
99,343
| – | – |
|
|
91
Medpace
MEDP
$13.5B
| $1.76M | 0.09% |
+8,097
| New | +$1.76M |
|
92
Paylocity
PCTY
$9.6B
| $1.71M | 0.09% |
7,220
| – | – |
|
93
Johnson & Johnson
JNJ
$429B
| $1.57M | 0.08% |
9,148
| – | – |
|
94
Fortinet
FTNT
$58.7B
| $1.5M | 0.08% |
4,160
-1,500
| -27% | -$539K |
|
95
Mastercard
MA
$536B
| $1.49M | 0.08% |
4,149
| – | – |
|
96
Humana
HUM
$37.5B
| $1.45M | 0.08% |
3,130
| – | – |
|
97
Biogen
BIIB
$20.8B
| $1.44M | 0.08% |
6,005
-300
| -5% | -$72K |
|
98
Vertex Pharmaceuticals
VRTX
$102B
| $1.41M | 0.07% |
6,406
-500
| -7% | -$110K |
|
99
Neurocrine Biosciences
NBIX
$13.5B
| $1.39M | 0.07% |
+16,361
| New | +$1.39M |
|
100
AllianceBernstein
AB
$4.37B
| $1.13M | 0.06% |
23,214
| – | – |
|